Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ophthalmology
  Free Subscription

Articles published in
Surv Ophthalmol
    November 2026
  1. MAI S, Chen J, Wang Y, Yu Y, et al
    Corticosteroids for the treatment of diabetic macular edema with massive hard exudates: An evidence-based update.
    Surv Ophthalmol. 2026;71:1665-1674.
    >> Share

  2. VON BARTHELD CS, Hagen MM, Jiang J, Yang W, et al
    The global prevalence of horizontal strabismus: A systematic review and meta-analysis with a focus on ethnic variation.
    Surv Ophthalmol. 2026;71:1803-1839.
    >> Share

  3. FORTE P, Feo A, Forte G, Bianco L, et al
    Schlaegel lines: History, etiology, multimodal imaging, and differential diagnosis of curvilinear streaks in chorioretinal disorders.
    Surv Ophthalmol. 2026;71:1641-1652.
    >> Share

  4. SADEK K, Yu P, Al-Burak SA, Osman R, et al
    The role of adjunctive aqueous suppressants for anti-vascular endothelial growth factor therapy: A systematic review.
    Surv Ophthalmol. 2026;71:1696-1703.
    >> Share

  5. TAO LR, Zhang WF, Chen YN, Wang ZC, et al
    The clinical and genetic profiles, management, and treatment outcomes of familial exudative vitreoretinopathy.
    Surv Ophthalmol. 2026;71:1840-1846.
    >> Share

  6. CHEN C, Wei W, Li F
    Retinopathy of prematurity training should be judged by competence, not exposure alone.
    Surv Ophthalmol. 2026;71:1847-1848.
    >> Share

    October 2026
  7. NAVEED F, Tao BK, Mihalache A, Popovic MM, et al
    Response to "Hydroxyurea and sickle cell retinopathy: Why association should not be interpreted as prevention".
    Surv Ophthalmol. 2026 Oct 22:S0039-6257(26)00151.
    >> Share

  8. SHAIKH MNK
    Hydroxyurea and Sickle Cell Retinopathy: Why Association Should Not Be Interpreted as Prevention.
    Surv Ophthalmol. 2026 Oct 21:S0039-6257(26)00150.
    >> Share

  9. HAOBIJAM B, Singh TH, Singh PT, Wu WC, et al
    Artificial intelligence in diabetic retinopathy: From deep learning to foundation models, clinical translation, and real-world deployment.
    Surv Ophthalmol. 2026 Oct 21:S0039-6257(26)00152.
    >> Share

  10. LI X, Yan R, Huang Y, Yu W, et al
    Subretinal fibrosis in neovascular age-related macular degeneration: From clinical features to fibrotic mechanisms and therapeutic opportunities.
    Surv Ophthalmol. 2026 Oct 21:S0039-6257(26)00149.
    >> Share

  11. GAGLIARDI OM, Chhablani J, Lupidi M, Saturno MC, et al
    Artificial intelligence (AI) and the choroidal challenge: A comprehensive review of AI applications in choroidal imaging.
    Surv Ophthalmol. 2026 Oct 16:S0039-6257(26)00148.
    >> Share

  12. FEO A, Tsui E
    Authors' Response to "Beyond inflammatory cell counts toward multidimensional imaging assessment in uveitis".
    Surv Ophthalmol. 2026 Oct 12:S0039-6257(26)00144.
    >> Share

  13. KASIKCI M, Alacamli G
    Beyond inflammatory cell counts toward multidimensional imaging assessment in uveitis.
    Surv Ophthalmol. 2026 Oct 8:S0039-6257(26)00145.
    >> Share

  14. AL-ANI A, Pham M, Mikhail D, Alkhawaja M, et al
    Diagnostic Accuracy and Clinical Impact of Ocular Fundus Imaging in the Emergency Department: A Systematic Review and Meta-Analysis.
    Surv Ophthalmol. 2026 Oct 8:S0039-6257(26)00146.
    >> Share

    September 2026
  15. MUNAJE MI, Idakwo U, Dingwoke EJ
    Rethinking delayed presentation in ophthalmology: A narrative review of biological and clinical consequences in resource-limited settings.
    Surv Ophthalmol. 2026 Sep 23:S0039-6257(26)00141.
    >> Share

  16. YALDO L, Abdelaal A, Ong J, Kiryakoza L, et al
    Effect of systemic fibrates on diabetic retinopathy prevention and progression: A comprehensive systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Sep 23:S0039-6257(26)00140.
    >> Share

  17. RUIZ-LOZANO RE, Bicket AK, Pitha I, Nallasamy N, et al
    Surgical applications of expanded polytetrafluorethylene in ophthalmology: A review.
    Surv Ophthalmol. 2026 Sep 17:S0039-6257(26)00138.
    >> Share

  18. LEI C, Zhao C, Guo S, Sintuwong S, et al
    Artificial intelligence in orbital diseases: opportunities, challenges, and future horizons.
    Surv Ophthalmol. 2026 Sep 17:S0039-6257(26)00139.
    >> Share

  19. BRACKENIER H, Van Aerschot J, Vermeer S, Stalmans I, et al
    Gene polymorphisms associated with progression of primary open-angle glaucoma: A systematic review.
    Surv Ophthalmol. 2026 Sep 17:S0039-6257(26)00137.
    >> Share

  20. GETAHUN H, Sharp CN, Tamirisa K, Kato K, et al
    Hemorrhagic posterior vitreous detachment: A comprehensive review of the risks of retinal breaks, detachment, and management options.
    Surv Ophthalmol. 2026 Sep 16:S0039-6257(26)00136.
    >> Share

  21. LUCCHINO L, Giuliano E, Giuliano F, Chiorrini R, et al
    Pharmacologic principles behind eye drop dosing: From pharmacokinetics to clinical practice.
    Surv Ophthalmol. 2026;71:1505-1516.
    >> Share

  22. SAHIN VURAL G, Akgun Z, Barut Selver O
    Beyond keratoplasty: The role of Descemet stripping only in the management of Fuchs endothelial dystrophy-a systematic review and meta-analysis.
    Surv Ophthalmol. 2026;71:1468-1477.
    >> Share

  23. ALGODI HS, Al-Burak SA, Zeng E, Tannar B, et al
    Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: An updated systematic review and meta-analysis.
    Surv Ophthalmol. 2026;71:1249-1260.
    >> Share

  24. HARJU N, Kauppinen A, Loukovaara S
    Aberrant angiogenesis, inflammation, and fibrosis in pediatric vitreoretinal surgical diseases.
    Surv Ophthalmol. 2026;71:1439-1446.
    >> Share

    August 2026
  25. HOLT C, Neidert C, Gedtal M, Virgili G, et al
    Corrigendum to "Prognostic factors for age-related macular degeneration progression: An overview of systematic reviews" [Surv Ophthalmol 71(3) (2025): 759-773].
    Surv Ophthalmol. 2026 Aug 29:S0039-6257(26)00123.
    >> Share

  26. TEOH CS, Kwak JJ, Lee CS
    Optic disc melanocytoma: Predicting visual field defects and recognizing malignant transformation - a review of current evidence.
    Surv Ophthalmol. 2026 Aug 18:S0039-6257(26)00120.
    >> Share

  27. ORTIZ-SELLER A, Real JT, Morcillo E, Ortiz JL, et al
    Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials.
    Surv Ophthalmol. 2026 Aug 18:S0039-6257(26)00121.
    >> Share

  28. HADDAD EN, Amin RS, Nero N, Hogue O, et al
    A systematic review and narrative synthesis of functional neuroimaging studies for chronic ocular surface pain.
    Surv Ophthalmol. 2026 Aug 12:S0039-6257(26)00118.
    >> Share

  29. ZHUANG X, Olivieri C, Neri G, Ricardi F, et al
    Macular atrophy in neovascular age-related macular degeneration: Prevalence, risk factors, imaging features, and clinical implications.
    Surv Ophthalmol. 2026 Aug 6:S0039-6257(26)00116.
    >> Share

  30. SONG A, Paul Chan RV
    Response to Letter to the Editor: Retinopathy of Prematurity Training Should Be Judged by Competence, Not Exposure Alone.
    Surv Ophthalmol. 2026 Aug 5:S0039-6257(26)00114.
    >> Share

    July 2026
  31. ABDALLA ELSAYED MEA, Dembele M, Marques JP, Xue K, et al
    Macular holes in inherited retinal dystrophies and vitreoretinopathies.
    Surv Ophthalmol. 2026 Jul 29:S0039-6257(26)00109.
    >> Share

  32. ZIAFATI M, Valizadeh Z, Rahimi S, Valizadeh A, et al
    Retinal and choroidal thickness alterations detected by optical coherence tomography in human immunodeficiency virus patients: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Jul 28:S0039-6257(26)00112.
    >> Share

  33. LIDUMS M, Ang T, Almater AI, DHSc Franzco DS, et al
    Orbital and periorbital amyloidosis: A systematic review of clinical characteristics, radiological features, management and systemic correlations.
    Surv Ophthalmol. 2026 Jul 28:S0039-6257(26)00113.
    >> Share

  34. VIENNE-JUMEAU A, Merle D, Sacconi R, Querques G, et al
    Non-exudative fluid in age-related macular degeneration: Imaging, pathophysiology, and clinical implications.
    Surv Ophthalmol. 2026 Jul 22:S0039-6257(26)00108.
    >> Share

  35. PAPAFOTIOU E, Arampatzis K, Ferreira A, Koumpoulis I, et al
    Prognostic value of subretinal hyperreflective material as an imaging biomarker in the treatment of neovascular age-related macular degeneration: A systematic review.
    Surv Ophthalmol. 2026 Jul 15:S0039-6257(26)00104.
    >> Share

  36. ASADIGANDOMANI H, Schwartz R, Reilly G, Amoozadehsamakoosh A, et al
    Acanthamoeba keratitis: Insights into diagnostic challenges and treatment advances.
    Surv Ophthalmol. 2026 Jul 14:S0039-6257(26)00103.
    >> Share

  37. PAPPAS CP, Cabrera-Aguas M, Watson SL
    Herpes simplex keratitis: An epidemiological and public health review.
    Surv Ophthalmol. 2026 Jul 11:S0039-6257(26)00094.
    >> Share

  38. INZUNZA A, Flanagan EP, Chen JJ
    Immune-mediated optic neuritis: A historical perspective.
    Surv Ophthalmol. 2026 Jul 10:S0039-6257(26)00092.
    >> Share

  39. LI J, Rowson AC, Naji L, Li S, et al
    Post-approval outcomes of voretigene neparvovec (Luxturna(R)) retinal gene therapy: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Jul 9:S0039-6257(26)00091.
    >> Share

  40. MOLLAPOUR BALLUJEH M, Asghari R, Abdali P, Mojmeli A, et al
    Optical coherence tomography and angiography for the assessment of retinal microvasculature in retinopathy of prematurity patients: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Jul 9:S0039-6257(26)00095.
    >> Share

  41. LAMATTINA KC, Zhou Y, Lauer DA, Brennan AT, et al
    Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors.
    Surv Ophthalmol. 2026 Jul 2:S0039-6257(26)00090.
    >> Share

  42. BANSAL AA, Sachdeva V, Kekunnaya R
    Infection post strabismus surgery: A review and case series.
    Surv Ophthalmol. 2026;71:1225-1235.
    >> Share

  43. SUNG J, Midorikawa-Inomata A, Fujio K, Inomata T, et al
    Expanding the horizon of oculomics: A narrative review on the emerging roles of the anterior segment and mobile health.
    Surv Ophthalmol. 2026;71:1074-1089.
    >> Share

  44. ARORA K, Gupta M, Gupta H, Sikka R, et al
    MicroRNAs as biomarkers and therapeutic targets in pterygia: A systematic review with quantitative synthesis.
    Surv Ophthalmol. 2026;71:1196-1205.
    >> Share

  45. VARGHESE D, Abdelsalam D, Ibrahim S, Lee AG, et al
    Too much of a good thing.
    Surv Ophthalmol. 2026;71:1236-1245.
    >> Share

  46. YANG HA, Jheng WL, Hwang YS, Wu WC, et al
    Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis.
    Surv Ophthalmol. 2026 Jul 1:S0039-6257(26)00088.
    >> Share

    June 2026
  47. ABDELAAL A, Kawji A, Gad W, Alzein A, et al
    Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.
    Surv Ophthalmol. 2026 Jun 27:S0039-6257(26)00086.
    >> Share

  48. SCHIAVETTI I, Lembo A, Bersani E, Nucci P, et al
    Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Jun 23:S0039-6257(26)00087.
    >> Share

  49. LUU B, van Dijk EHC, Hein M, An D, et al
    Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapy.
    Surv Ophthalmol. 2026 Jun 18:S0039-6257(26)00084.
    >> Share

  50. DAVE S, Solebo AL
    Comment on "Quantitative imaging for assessing uveitis activity: A comprehensive review".
    Surv Ophthalmol. 2026 Jun 18:S0039-6257(26)00083.
    >> Share

  51. AGIN A, Artunay O
    Postoperative hypotony after retinectomy in rhegmatogenous retinal detachment surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Jun 6:S0039-6257(26)00081.
    >> Share

  52. NAVEED F, Tao BK, Ashamalla M, Mihalache A, et al
    Association of hydroxyurea use and sickle cell retinopathy: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Jun 3:S0039-6257(26)00076.
    >> Share

  53. WONG D, Chua J, Hemelings R, Tan B, et al
    Update on the structure-Function relationship in glaucoma.
    Surv Ophthalmol. 2026 Jun 3:S0039-6257(26)00077.
    >> Share

  54. PARIS J, Almater AI, Mackenzie C, Ang T, et al
    Orbital involvement in sickle cell disease: A systematic review.
    Surv Ophthalmol. 2026 Jun 3:S0039-6257(26)00078.
    >> Share

    May 2026
  55. OUYANG CMH, Fan L, Kandel H, Watson SL, et al
    Xerophthalmia and ocular manifestations of vitamin A deficiency in children in high-income countries: A systematic review.
    Surv Ophthalmol. 2026 May 22:S0039-6257(26)00073.
    >> Share

  56. NADIMPALLI S, Vijendran S, Bhandary SV
    Disorganization of inner retinal layers and disruption of outer retinal layers as predictors of anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema: A scoping review.
    Surv Ophthalmol. 2026 May 22:S0039-6257(26)00061.
    >> Share

  57. ZHAO X, Wu Z, Wu S, Cui K, et al
    Multimodal artificial intelligence in retinopathy of prematurity: A comprehensive narrative review.
    Surv Ophthalmol. 2026 May 13:S0039-6257(26)00063.
    >> Share

  58. AHMAD N, Chaaya C, Pandiri S, Malek D, et al
    Retinopathy of prematurity: A global review of screening guidelines.
    Surv Ophthalmol. 2026 May 7:S0039-6257(26)00064.
    >> Share

  59. GASSAMA S, Bastelica P, Baudouin C, Labbe A, et al
    Glaucoma filtering surgery combined with phacoemulsification in the era of new aqueous humor filtration devices: A systematic review.
    Surv Ophthalmol. 2026 May 6:S0039-6257(26)00054.
    >> Share

  60. LI Y, Tao Y, Wu J, He Y, et al
    Dynamic regulation mechanisms of macrophages and advances in targeted therapy for corneal injury repair.
    Surv Ophthalmol. 2026 May 3:S0039-6257(26)00053.
    >> Share

  61. GAO J, Liu M, Liu X, Zhang M, et al
    Multi-omics panorama of glaucoma: Pathogenesis, biomarkers, and novel therapeutic strategies.
    Surv Ophthalmol. 2026 May 2:S0039-6257(26)00055.
    >> Share

  62. NABAVI A, Zarei M, Shome A, Rupenthal ID, et al
    Quantitative imaging for assessing uveitis activity: A comprehensive review.
    Surv Ophthalmol. 2026 May 2:S0039-6257(26)00058.
    >> Share

  63. PARELLADA SE, Avaiya K, Elnour KM, Armstrong ML, et al
    Assessing the 3 pillars of housing for eye and vision health outcomes: A scoping review.
    Surv Ophthalmol. 2026;71:997-1005.
    >> Share

  64. TAN JH, Zhao W, Ren H, Zhang BW, et al
    Comparison of the efficacy of unilateral amblyopia treatments: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2026;71:960-972.
    >> Share

  65. MIRMOHAMMADSADEGHI A, Sadeghi E, Akbari MR, Sadeghi M, et al
    Accuracy and clinical utility of ultrasound biomicroscopy in extraocular muscle imaging: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026;71:951-959.
    >> Share

  66. KANG S, Hsu J, Yoo SH
    Pseudophakic mini-monovision.
    Surv Ophthalmol. 2026;71:973-979.
    >> Share

  67. CAMPOS A, Mota C, Cruz H, Sousa JP, et al
    Pseudophakic macular edema: Review and new insights on treatment and prophylaxis.
    Surv Ophthalmol. 2026;71:817-826.
    >> Share

  68. WU D, Lim BX, Sundar G, Singh S, et al
    The evaluation and management of dry anophthalmic socket syndrome.
    Surv Ophthalmol. 2026;71:925-940.
    >> Share

  69. CICINELLI MV, Frizziero L, Sarao V, Cennamo G, et al
    Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants.
    Surv Ophthalmol. 2026 May 1:S0039-6257(26)00056.
    >> Share

  70. ZHANG XJ, Liu M, Yu M, Fung Ho EC, et al
    Efficacy, tolerability, and threshold effect of atropine eye drops for myopia control: A systematic review and dose-response meta-analysis.
    Surv Ophthalmol. 2026 May 1:S0039-6257(26)00052.
    >> Share

    April 2026
  71. KHANNA RK, Cui X, Wong DCS, Makam R, et al
    Omics in hereditary optic neuropathies:A systematic review of clinical studies with an integrated point of view.
    Surv Ophthalmol. 2026 Apr 28:S0039-6257(26)00059.
    >> Share

  72. MANKAL S, Saidkasimova S, Lim TH, Steele TWJ, et al
    Current and future applications of intraocular bioadhesives in vitreoretinal surgery.
    Surv Ophthalmol. 2026 Apr 2:S0039-6257(26)00049.
    >> Share

    March 2026
  73. VON DER EMDE L, Reiter GS, Mallwitz M, Jauch AS, et al
    Quantitative fundus autofluorescence in age-related macular degeneration.
    Surv Ophthalmol. 2026 Mar 31:S0039-6257(26)00051.
    >> Share

  74. TORRES-COSTA S, Machado S, Barbosa G, Carvalho E, et al
    Artificial intelligence in retinal vein occlusion: Current applications, challenges, and future directions.
    Surv Ophthalmol. 2026 Mar 30:S0039-6257(26)00047.
    >> Share

  75. SADEK K, Yu P, Butt FR, Tao BK, et al
    Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Mar 28:S0039-6257(26)00050.
    >> Share

  76. XU Q, Zhu H, Gong C
    Laboratory tests of ocular toxocariasis: From pathological diagnosis to immunological diagnosis.
    Surv Ophthalmol. 2026 Mar 24:S0039-6257(26)00048.
    >> Share

  77. MARTYKA A, Bolek B, Gospodarczyk N, Czuj W, et al
    Therapeutic potential of norrin/FZD4/beta-catenin signaling in blood-retinal barrier protection.
    Surv Ophthalmol. 2026 Mar 18:S0039-6257(26)00044.
    >> Share

  78. VERA-DUARTE GR, Ortiz-Morales G, Guerrero-Acosta JC, Carrete-Corral SA, et al
    Atopic Keratoconjunctivitis: From Molecular Mechanisms to Clinical Implications.
    Surv Ophthalmol. 2026 Mar 17:S0039-6257(26)00043.
    >> Share

  79. BUSZA AM, Lyons CE, Hamzeh N, Mohammadi S, et al
    Optical coherence tomography angiography in pediatric and adult populations: A comprehensive review.
    Surv Ophthalmol. 2026 Mar 11:S0039-6257(26)00042.
    >> Share

  80. QUARTA A, Feo A, Boscia G, Savastano A, et al
    Inner retinal surface abnormalities: Imaging phenotypes, quantitative features, and mechanistic insights across surgical and nonsurgical conditions.
    Surv Ophthalmol. 2026 Mar 11:S0039-6257(26)00038.
    >> Share

  81. RIZZO C, Mercuri S, Savastano MC, Govetto A, et al
    Peripheral retinal degenerations: A review of peripheral optical coherence tomography applications in their diagnosis and visualization.
    Surv Ophthalmol. 2026 Mar 11:S0039-6257(26)00040.
    >> Share

  82. JURKIEWICZ T, Marty AS
    William W. Cooper, and his epidemiological study "On the conical cornea" of 1850.
    Surv Ophthalmol. 2026 Mar 10:S0039-6257(26)00036.
    >> Share

  83. WANG IM, Tsai IL
    Comparative Pathogenesis and Management of Orbital/Conjunctival and Gastric MALT Lymphoma: Microbial Drivers, Molecular Mechanisms, and Therapeutic Implications.
    Surv Ophthalmol. 2026 Mar 10:S0039-6257(26)00041.
    >> Share

  84. SHEIBANI K, Bayat K, Rajavi Z, Abdi S, et al
    Ophthalmic manifestations in preterm children without retinopathy of prematurity: A review.
    Surv Ophthalmol. 2026 Mar 10:S0039-6257(26)00034.
    >> Share

  85. LINGHU D, Zhu X, Liang J, Cheng Y, et al
    Efficacy and safety of conbercept, ranibizumab and laser in retinopathy of prematurity: a systematic review and network meta-analysis.
    Surv Ophthalmol. 2026 Mar 6:S0039-6257(26)00035.
    >> Share

  86. QUARTA A, Feo A, Corradetti G, Popovic MM, et al
    Double layer sign in chorioretinal diseases: Clinical significance and implications from multimodal imaging.
    Surv Ophthalmol. 2026;71:456-466.
    >> Share

  87. ALBERTOS-ARRANZ H, Juvier-Riesgo T, Sainfort F, Jayakar A, et al
    A scoping review on clinical and genetic diagnostic approaches for cerebral visual impairment.
    Surv Ophthalmol. 2026;71:647-661.
    >> Share

  88. HUANG S, Tong JY, Juniat V, Almater A, et al
    Radiological features of lacrimal gland masses.
    Surv Ophthalmol. 2026;71:700-717.
    >> Share

  89. CARLA MM, Philippakis E, Gaucher D, Couturier A, et al
    Current advances in dome-shaped macula and associated conditions.
    Surv Ophthalmol. 2026;71:393-404.
    >> Share

  90. VENKATESH R DR, Hande P Dr, Prabhu V Dr, Vidyasagar S Dr, et al
    Dissecting the clinical and pathophysiological complexity of fundus tessellation.
    Surv Ophthalmol. 2026;71:382-392.
    >> Share

  91. PARMAR UPS, Arora A, Agarwal A, Gangaputra S, et al
    Detection and quantification of fluorescein angiography leakage: From manual grading to advances in machine learning.
    Surv Ophthalmol. 2026;71:613-626.
    >> Share

  92. NOURI H, Hasan N, Abtahi SH, Ahmadieh H, et al
    Deep learning in central serous chorioretinopathy.
    Surv Ophthalmol. 2026;71:718-748.
    >> Share

  93. HOOPER CY, Ferreira LB, Vaze A, Vasconcelos-Santos DV, et al
    Relentless placoid chorioretinitis.
    Surv Ophthalmol. 2026;71:467-482.
    >> Share

  94. CHENG JY, Hsu D, Feo A, Liu V, et al
    Chorioretinal folds: A review and update of new and old etiologies.
    Surv Ophthalmol. 2026;71:405-422.
    >> Share

    February 2026
  95. SIM SY, Lim LT, Chaudhary S, Musa M, et al
    Update on subthreshold micropulse laser treatment for retinal diseases: A narrative review.
    Surv Ophthalmol. 2026 Feb 26:S0039-6257(26)00022.
    >> Share

  96. ZHANG C, Xu Z
    Advancements of ultrasound modalities and their clinical potential in ophthalmology.
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00021.
    >> Share

  97. KORKMAZ I, Palamar M
    Complications of corneal crosslinking: What can go wrong?
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00023.
    >> Share

  98. MURATI F, Ghahari P, Zvavamwe T, Williams WW, et al
    Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidence.
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00024.
    >> Share

  99. ZIEMSSEN F, Loewenstein A, Aslam TM
    Effective communication strategies in intravitreal therapy: How to listen and how to talk to people who need injections in their eyes.
    Surv Ophthalmol. 2026 Feb 24:S0039-6257(26)00025.
    >> Share

  100. FERRO DESIDERI L, Fukuhara PS, Wintergerst MWM, Meyer CH, et al
    Ocular inflammation after intraocular drug delivery: Mechanisms, risk factors, and implications for clinical practice.
    Surv Ophthalmol. 2026 Feb 17:S0039-6257(26)00019.
    >> Share

  101. KHILJI M, Hira S, Ahmed Z, Ansar S, et al
    Safety and efficacy of anti-vascular endothelial growth factor (VEGF) plus corticosteroids versus anti-VEGF alone for macular edema from retinal vein occlusion: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026 Feb 14:S0039-6257(26)00018.
    >> Share

  102. SUSIYANTI M, Febrina F, Putera I, Jelita A, et al
    Metagenomic sequencing in various ocular infections: A systematic review of diagnostic utility.
    Surv Ophthalmol. 2026 Feb 6:S0039-6257(26)00014.
    >> Share

  103. CASTRO-FERNANDEZ DC, Canizo-Outerino A, Cuartero-Martinez A, Gil-Martinez M, et al
    A systematic review on age-related macular degeneration: New insights from multi-omics studies.
    Surv Ophthalmol. 2026 Feb 3:S0039-6257(26)00016.
    >> Share

    January 2026
  104. GHARBI K, Wijngaarden PV, Hadoux X
    Foundation models for ophthalmic imaging.
    Surv Ophthalmol. 2026 Jan 29:S0039-6257(26)00012.
    >> Share

  105. HUANG L, Chen A, Zhang Q, Zhu J, et al
    Ocular frailty: A concept analysis.
    Surv Ophthalmol. 2026 Jan 28:S0039-6257(26)00013.
    >> Share

  106. SALH D, Pickard MR, Al-Mehiawi A, Parker R, et al
    Exploring successful treatments for upper eyelid retraction in thyroid eye disease: A scoping review.
    Surv Ophthalmol. 2026 Jan 25:S0039-6257(26)00011.
    >> Share

  107. LA ROSA A, Feo A, Govetto A, Rossi T, et al
    Prognostic factors after rhegmatogenous retinal detachment repair: An overview of the clinical and imaging insights.
    Surv Ophthalmol. 2026 Jan 8:S0039-6257(26)00002.
    >> Share

  108. NAIR S, Deshmukh R, Mohan S, Agarwal T, et al
    Corneal transplantation triple procedures.
    Surv Ophthalmol. 2026 Jan 2:S0039-6257(25)00235.
    >> Share

  109. HUANG A, Zhang A, Lee D, Ying GS, et al
    Placebo or vehicle effects on dry eye signs and symptoms in randomized controlled trials: A systematic review and meta-analysis.
    Surv Ophthalmol. 2026;71:207-214.
    >> Share

  110. VENKATESH R, Prabhu V, Hande P, Tendulkar K, et al
    Controversies and conundrums in pachychoroid spectrum disorders: A structured diagnostic approach.
    Surv Ophthalmol. 2026;71:25-34.
    >> Share

  111. RUGGERI ML, Romano MR, Rossi T, Bacherini D, et al
    Silicone oil removal-related vision loss.
    Surv Ophthalmol. 2026;71:61-70.
    >> Share

  112. CARLA MM, Giannuzzi F, Hu L, Rizzo C, et al
    The human amniotic membrane in vitreoretinal surgery: Applications, outcomes and limitations.
    Surv Ophthalmol. 2026;71:14-24.
    >> Share

  113. GOWDA A, Wood JPM, Chidlow G, Casson RJ, et al
    Laser-induced histopathological changes to the retina: A review.
    Surv Ophthalmol. 2026;71:53-60.
    >> Share

  114. ZHANG H, Li Z, Chan HC, Song X, et al
    Artificial intelligence in thyroid eye disease imaging: A systematic review.
    Surv Ophthalmol. 2026;71:142-157.
    >> Share

  115. SHEN Y, Frauches R, Zhao J, Lo CH, et al
    Pathophysiology of intraoperative floppy iris syndrome: An unsettled debate.
    Surv Ophthalmol. 2026;71:200-206.
    >> Share

    December 2025
  116. BALA S, Allan KC, Decker NL, Abbass NJ, et al
    Glucagon-like peptide-1 receptor agonists: What ophthalmologists need to know.
    Surv Ophthalmol. 2025 Dec 31:S0039-6257(25)00236.
    >> Share

  117. CHEN KY, Chan HC, Chan CM
    Is intra-arterial chemotherapy superior to conventional chemotherapy for retinoblastoma? A systematic review and meta-analysis of efficacy and safety.
    Surv Ophthalmol. 2025 Dec 31:S0039-6257(25)00234.
    >> Share

  118. LAI A, Issa M, Pereira A, Ghafri MA, et al
    Age-related choroidal atrophy: A systematic review of multimodal imaging, clinical features, and differentiation from other forms of macular degeneration.
    Surv Ophthalmol. 2025 Dec 18:S0039-6257(25)00232.
    >> Share

  119. CHYCHKO L, Son HS, Friedrich M, Yildirim TM, et al
    The diagnostic potential of aqueous humor: Unlocking ocular and systemic insights.
    Surv Ophthalmol. 2025 Dec 17:S0039-6257(25)00231.
    >> Share

  120. HOLT CA, Niedert C, Gedtal M, Virgili G, et al
    Prognostic factors for age-related macular degeneration progression: An overview of systematic reviews.
    Surv Ophthalmol. 2025 Dec 16:S0039-6257(25)00230.
    >> Share

  121. WANG TW, Luo WT, Tu YK, Chou YB, et al
    Prospective validation of deep-learning algorithms for diabetic retinopathy screening: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Dec 2:S0039-6257(25)00226.
    >> Share

  122. NABAVI A, Haddock LJ, Mahmoudi A, Salabati M, et al
    Retinal nerve fiber layer thickness as a biomarker of uveitis activity: A systematic review.
    Surv Ophthalmol. 2025 Dec 2:S0039-6257(25)00228.
    >> Share

  123. JAYADEV C, Tendulkar K, Vidyasagar S, Gambhir V, et al
    The downside of tamponade: Silicone oil emulsification and its ocular impact.
    Surv Ophthalmol. 2025 Dec 2:S0039-6257(25)00229.
    >> Share

    November 2025
  124. GRIECO G, Carla MM, Di Stefano G, Scampoli A, et al
    Updates on surgical and nonsurgical innovations for macular hole treatment.
    Surv Ophthalmol. 2025 Nov 12:S0039-6257(25)00215.
    >> Share

  125. PORTENY JR, Scudder P, Darlow BA, Vanderveen DK, et al
    A scoping review of adverse visual outcomes among preterm infants without, versus those with, retinopathy of prematurity.
    Surv Ophthalmol. 2025 Nov 11:S0039-6257(25)00214.
    >> Share

  126. RASHID M, Azeem S, Shahid IF, Ali MKB, et al
    Efficacy and safety of aflibercept biosimilars compared to reference aflibercept for retinal diseases: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Nov 11:S0039-6257(25)00213.
    >> Share

  127. TONG JY, Sung J, Chan W, Psaltis AJ, et al
    Transorbital endoscopic approaches: Applications in orbital surgery.
    Surv Ophthalmol. 2025 Nov 7:S0039-6257(25)00198.
    >> Share

  128. ZHANG C, Xia Z, Mao W, Lin Z, et al
    Optical coherence tomography angiogropahy changes in patients with diabetic retinopathy treated with panretinal photocoagulation: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Nov 7:S0039-6257(25)00196.
    >> Share

  129. FEO A, Tailor PD, Au A, Wu A, et al
    Anterior segment optical coherence tomography in uveitis: A comprehensive review of clinical applications, diagnostic insights, and future directions.
    Surv Ophthalmol. 2025 Nov 5:S0039-6257(25)00197.
    >> Share

  130. BAYAT K, Pooyan P, Feizi S, Ahmadieh H, et al
    Structural alterations in the retina and choroid of keratoconus patients detected by optical coherence tomography: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Nov 4:S0039-6257(25)00195.
    >> Share

  131. APHALE P, Shekhar H, Dokania S
    Comments on "Refining the translational pathway for senotherapeutics in age-related macular degeneration: Insights on biomarkers, delivery strategies, and clinical trial design".
    Surv Ophthalmol. 2025 Nov 3:S0039-6257(25)00191.
    >> Share

  132. CHEN KY, Chan HC, Chan CM
    Response letter to "Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: Correspondence".
    Surv Ophthalmol. 2025 Nov 2:S0039-6257(25)00189.
    >> Share

  133. BHATTI MT, Moore JG, Hwang TN, Bilyk JR, et al
    Blow.
    Surv Ophthalmol. 2025;70:1261-1266.
    >> Share

  134. COUTURIER A, Wykoff CC, Lupidi M, Udaondo P, et al
    Anatomic biomarkers as potential endpoints in diabetic macular edema: A systematic literature review with identification of macular volume as a key surrogate for visual acuity.
    Surv Ophthalmol. 2025;70:1090-1110.
    >> Share

  135. ZHANG P, Xu Z
    The advancements in precision medicine for Leber congenital amaurosis: Breakthroughs from genetic diagnosis to therapy.
    Surv Ophthalmol. 2025;70:1205-1219.
    >> Share

  136. LEE SH, Ho YR, Li H, Tu YK, et al
    Prevalence and clinical manifestations of cytomegalovirus infection in patients with Posner-Schlossman syndrome: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025;70:1252-1260.
    >> Share

    October 2025
  137. DAUNGSUPAWONG H, Wiwanitkit V
    Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: Correspondence.
    Surv Ophthalmol. 2025 Oct 29:S0039-6257(25)00192.
    >> Share

  138. DEIMAZAR G, Sabbaghi H, Ahmadieh H, Sheikhtaheri A, et al
    Artificial intelligence for detection of age-related macular degeneration based on fundus images: A systematic review.
    Surv Ophthalmol. 2025 Oct 29:S0039-6257(25)00193.
    >> Share

  139. CHEN Y, Jiang F, Zhang M
    Response to Comments on Refining the translational pathway for senotherapeutics in age-related macular degeneration: Insights on biomarkers, delivery strategies, and clinical trial design.
    Surv Ophthalmol. 2025 Oct 28:S0039-6257(25)00190.
    >> Share

  140. NUSAIR O, Soleimani M
    Additional observations on ROCK inhibitors: Reticular corneal epithelial edema.
    Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00187.
    >> Share

  141. PARIS JE, Macri CZ, Lee YM, Chan WO, et al
    Retinal imaging options for differentiating degenerative retinoschisis from retinal detachment: A scoping review.
    Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00145.
    >> Share

  142. HENEIN C, Tan JK, Steel DH, Ahmad S, et al
    Response to "Additional observations on ROCK inhibitors: reticular corneal epithelial edema".
    Surv Ophthalmol. 2025 Oct 3:S0039-6257(25)00186.
    >> Share

  143. LIU Y, Gong D, Dang K, Guo J, et al
    Diagnostic accuracy of next generation sequencing--based genetic research for primary glaucoma: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00181.
    >> Share

  144. TAO BK, Hwang J, Park S, Mikhail D, et al
    Prefilled syringes and post-intravitreal injection endophthalmitis: A network meta-analysis.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00184.
    >> Share

  145. GHALIBAFAN S, Herskowitz WR, Chou BG, Rohowetz LJ, et al
    Isolated tattoo-associated uveitis without systemic sarcoidosis: A systematic review of case reports.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00183.
    >> Share

  146. MERLE DA, Beretta F, Sacconi R, Querques G, et al
    Fibrogliosis in neovascular age-related macular degeneration: A new mechanistic perspective.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00185.
    >> Share

  147. FEIZI S, Hatami F, Mirzaei SK, Bayat K, et al
    Medical and surgical approaches to prevent corneal graft rejection in high-risk recipients.
    Surv Ophthalmol. 2025 Oct 1:S0039-6257(25)00182.
    >> Share

    September 2025
  148. ESHRAGHI B, Babaei L, Aghajani A
    Altered ocular surface microbiome in nasolacrimal duct obstruction: Clinical Implications for intraocular surgery.
    Surv Ophthalmol. 2025 Sep 22:S0039-6257(25)00178.
    >> Share

  149. TSENG YH, Wu PL, Kang EY, Chen KJ, et al
    Advancements in ocular blood flow imaging: Clinical applications of laser speckle flowgraphy and optical coherence tomography angiography in retinal and choroidal vascular diseases.
    Surv Ophthalmol. 2025 Sep 21:S0039-6257(25)00180.
    >> Share

  150. SABOYA-GALINDO P, Cifuentes-Gonzalez C, Rojas-Carabali W, Mejia-Salgado G, et al
    Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A Systematic Review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) - Report 4.
    Surv Ophthalmol. 2025 Sep 20:S0039-6257(25)00173.
    >> Share

  151. LEE E, Hunt D, Cakir Y, Kuo D, et al
    Artificial intelligence in age-related macular degeneration: Advancing diagnosis, prognosis, and treatment.
    Surv Ophthalmol. 2025 Sep 18:S0039-6257(25)00174.
    >> Share

  152. SUGANYA DEVI K, Vasireddi HK, Reddy GR, Satti SK, et al
    Unfolding the diagnostic pipeline of diabetic retinopathy with artificial intelligence: A systematic review.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00170.
    >> Share

  153. CIFUENTES-GONZALEZ CG, Putera I, Walter CFY, Mejia-Salgado MS, et al
    Work-up in patients with retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 2.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00175.
    >> Share

  154. LA ROSA A, Feo A, Bousquet E, Cabral D, et al
    Angioid streaks-related choroidal neovascularization: Clinical features, multimodal imaging-based differential diagnosis, and optimized treatment strategies.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00169.
    >> Share

  155. NANJI K, Hatamnejad A, Grad J, El-Sayes A, et al
    Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review.
    Surv Ophthalmol. 2025 Sep 17:S0039-6257(25)00176.
    >> Share

  156. KOCAK I, Sayin N, Bayramoglu SE, Thalib L, et al
    Effect of methotrexate in preventing retinal detachment after proliferative vitreoretinopathy surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Sep 16:S0039-6257(25)00177.
    >> Share

  157. SUMODHEE D, Ioannidou E, Ramessur R, Prashar J, et al
    Interventions to improve patients' knowledge in ophthalmology: A systematic review and narrative synthesis.
    Surv Ophthalmol. 2025 Sep 13:S0039-6257(25)00168.
    >> Share

  158. LOH NC, Rojas-Carabali W, Lim YH, Bong JE, et al
    Choroidal Vascularity Index as a marker of health and disease: Systematic review and meta-Analyses.
    Surv Ophthalmol. 2025 Sep 5:S0039-6257(25)00164.
    >> Share

  159. HATAMNEJAD A, Nanji K, Grad J, El-Sayes A, et al
    Predicting Treatment Response in Retinal Vein Occlusions Using Baseline Optical Coherence Tomography Biomarkers: A Systematic Review.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00148.
    >> Share

  160. SONG W, Chen W, Chi J, Liu X, et al
    The role of lipid metabolism disorder in the progression and treatment of ocular vascular diseases.
    Surv Ophthalmol. 2025 Sep 4:S0039-6257(25)00163.
    >> Share

  161. LIU C, Yan R, Jiang J
    Adjustable suture versus nonadjustable suture surgery for childhood strabismus: A meta-analysis.
    Surv Ophthalmol. 2025;70:859-867.
    >> Share

  162. CARLA MM, Ripa M, Crincoli E, Catania F, et al
    The spectrum of microcystic macular edema: Pathogenetic insights, clinical entities, and functional prognosis.
    Surv Ophthalmol. 2025;70:982-994.
    >> Share

  163. JEAN-CHARLES S, Shoji MK, Kikkawa DO, Bhatti MT, et al
    The mirrored arterial dilemma.
    Surv Ophthalmol. 2025;70:1029-1033.
    >> Share

    August 2025
  164. GIANNOPOULOS NG, Macri CZ, Seneviratne IAK, Bacchi S, et al
    A narrative review of the psychological impact of intravitreal injections.
    Surv Ophthalmol. 2025 Aug 28:S0039-6257(25)00144.
    >> Share

  165. MOZAFAR M, Fekrazad S, Amanollahi M, Samiee R, et al
    Optical coherence tomography angiography measurements in thyroid eye disease: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00143.
    >> Share

  166. MALOOF AG, Zhang S, Pavic NV, Coroneo MT, et al
    'Seeing both sides': A systematic review of the Miyake-Apple video system's role in Ophthalmology.
    Surv Ophthalmol. 2025 Aug 20:S0039-6257(25)00134.
    >> Share

  167. QIAN Y, Lin X, Wang Y, Mao Y, et al
    In vivo detection of macrophage-like cells at the vitreoretinal interface in retinal diseases using optical coherence tomography angiography.
    Surv Ophthalmol. 2025 Aug 19:S0039-6257(25)00141.
    >> Share

  168. LE NVA, Nguyen NC, Kasetsuwan N, Reinprayoon U, et al
    Corrigendum to "Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis" [Survey Ophthalomol., vol. 70 (2025) P480-488/ PMID: 39709033].
    Surv Ophthalmol. 2025 Aug 18:S0039-6257(25)00137.
    >> Share

  169. SEN M, Munier FL, Honavar SG
    Intraocular seeds in retinoblastoma: A review of classification, management, and outcomes.
    Surv Ophthalmol. 2025 Aug 15:S0039-6257(25)00139.
    >> Share

  170. RAJESWAREN V, Trivedi V, Yoganathan P
    Macular hole after anti-Vascular Endothelial Growth factor injection: A review.
    Surv Ophthalmol. 2025 Aug 14:S0039-6257(25)00140.
    >> Share

  171. PARIS JE, Macri CZ, Lake SR, Chan WO, et al
    Risk factors for retinal breaks following surgical induction of posterior vitreous detachment: A scoping review.
    Surv Ophthalmol. 2025 Aug 12:S0039-6257(25)00138.
    >> Share

  172. DIRANI K, Kim C, Park J, Gregory A, et al
    Clinical Implications of heavy silicon oil (Densiron(R)) endotamponade after pars plana vitrectomy: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Aug 7:S0039-6257(25)00132.
    >> Share

  173. GAO J, Wang W, Mo Y
    Retinal Degenerative Diseases: Complement system-Microglia Crosstalk.
    Surv Ophthalmol. 2025 Aug 5:S0039-6257(25)00135.
    >> Share

    July 2025
  174. HE M, Yang Z, Shi Z, Chen Y, et al
    Clinical features, management, and prognosis factors of traumatic optic neuropathy.
    Surv Ophthalmol. 2025 Jul 30:S0039-6257(25)00129.
    >> Share

  175. CARLA MM, Mottola F, Cusato M, Oreste G, et al
    Vitreoretinal interface abnormalities in age-related macular degeneration: Prevalence, pathophysiology, and reciprocal influence.
    Surv Ophthalmol. 2025 Jul 23:S0039-6257(25)00126.
    >> Share

  176. DRAKOPOULOS M, Nadel A, Bains HK, Bisen JB, et al
    Quantitative ophthalmic posterior segment optical coherence tomography angiography and systemic conditions.
    Surv Ophthalmol. 2025 Jul 21:S0039-6257(25)00123.
    >> Share

  177. ZHANG HY, Smith AW, Laferriere HE, Finn AP, et al
    The use of time-driven activity-based costing in ophthalmology: A scoping review.
    Surv Ophthalmol. 2025 Jul 19:S0039-6257(25)00122.
    >> Share

  178. JIN K, Yu T, Grzybowski A
    Multimodal artificial intelligence in ophthalmology: Applications, challenges, and future directions.
    Surv Ophthalmol. 2025 Jul 17:S0039-6257(25)00120.
    >> Share

  179. SUH A, Szeto JJ, Ong J, Armstrong GW, et al
    Ocular trauma in microgravity: In-flight diagnostics and extraterrestrial strategies for management.
    Surv Ophthalmol. 2025 Jul 15:S0039-6257(25)00124.
    >> Share

  180. CARLA MM, Couturier A, Mottola F, Cusato M, et al
    The influence of scleral buckle on choroidal architecture: An unexplored link with the spectrum of acquired overload choroidopathy?
    Surv Ophthalmol. 2025 Jul 9:S0039-6257(25)00108.
    >> Share

  181. WAN Y, Guo X, Wang N
    Trabecular meshwork: A pivotal target for evolving glaucoma treatments.
    Surv Ophthalmol. 2025 Jul 8:S0039-6257(25)00107.
    >> Share

  182. VILARES-MORGADO R, Verbruggen K, Stalmans I, Barbosa-Breda J, et al
    Age-related changes in optical coherence tomography glaucoma-related parameters: A systematic review.
    Surv Ophthalmol. 2025 Jul 3:S0039-6257(25)00104.
    >> Share

  183. KHOSRAVI MIRZAEI S, Hatami F, Safi S, Khorrami Z, et al
    Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025;70:633-644.
    >> Share

  184. JAIN M, Mohankumar A, Torres J, Alkorbi HA, et al
    Pharmacological associations of central serous chorioretinopathy: Looking beyond corticosteroids.
    Surv Ophthalmol. 2025;70:616-632.
    >> Share

  185. ARRUDA MP, Hira S, Lima RV, Barbosa LIT, et al
    Pharmacological therapy for relieving pain in panretinal photocoagulation: A network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025;70:645-652.
    >> Share

  186. SHETH JU, Stewart MW, Narayanan R, Anantharaman G, et al
    Macular neovascularization.
    Surv Ophthalmol. 2025;70:653-675.
    >> Share

  187. WOUDSTRA-DE JONG JE, Busschbach JJ, Manning-Charalampidou SS, Vingerling JR, et al
    Assessment of patient-reported outcomes in vitreomacular interface disorders: A systematic literature review.
    Surv Ophthalmol. 2025;70:685-694.
    >> Share

  188. MELENDEZ-MORENO A, Yesiltas YS, Jacquelyn Wrenn NP, Singh AD, et al
    Corrigendum to "Iris melanoma: Prognostication for metastasis"[Survey Ophthalmol 68 (2023) 957-963].
    Surv Ophthalmol. 2025 Jul 1:S0039-6257(25)00106.
    >> Share

    June 2025
  189. SONG A, Lee E, Ostmo SR, Jonas KE, et al
    Retinopathy of prematurity training and education: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00102.
    >> Share

  190. VON DER EMDE L, Petzinna SM, Herwig-Carl MC, Adamson MS, et al
    Advances in diagnosing and treating giant cell arteritis: New hope for arteritic anterior ischemic optic neuropathy.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00103.
    >> Share

  191. YANG WYL, Wong HJ, Fu CE, Rojas-Carabali W, et al
    Artificial intelligence in the prediction of glaucoma development and progression: A systematic review.
    Surv Ophthalmol. 2025 Jun 18:S0039-6257(25)00105.
    >> Share

  192. HAMMOUD B, Schumacher JS, Zhang H, Dutra BAL, et al
    Brillouin microscopy for focal biomechanical measurements in normal and keratoconic corneas: A narrative review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00099.
    >> Share

  193. TOVEY CRUTCHFIELD EC, Vincent AL, Anjou MD, Taylor HR, et al
    Inherited retinal disease in global Indigenous populations: A scoping review.
    Surv Ophthalmol. 2025 Jun 11:S0039-6257(25)00101.
    >> Share

  194. WOO J, Chopra S, Liu K, Tuttle B, et al
    Impact of neighborhood-level deprivation on glaucoma prevalence and treatment: A review of the literature.
    Surv Ophthalmol. 2025 Jun 10:S0039-6257(25)00100.
    >> Share

  195. HAN L, Mao Y, Sang Q, Wan Y, et al
    Efficacy and complications of microcatheter-assisted minimally invasive glaucoma surgery for open-angle glaucoma: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2025 Jun 6:S0039-6257(25)00097.
    >> Share

    May 2025
  196. ALKHABAZ A, Pujari R, Ren Y, Smith SJ, et al
    Optic disc drusen-associated neovascularization: A systematic review.
    Surv Ophthalmol. 2025 May 27:S0039-6257(25)00095.
    >> Share

  197. CHEN KY, Chan HC, Chan CM
    Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: A systematic review and network meta-analysis of randomized controlled trials.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00096.
    >> Share

  198. KHAN MMH, Akhlaq A, Khan MJ, Ali M, et al
    Impact of social determinants of health on causes of ophthalmic trauma: A narrative review.
    Surv Ophthalmol. 2025 May 24:S0039-6257(25)00091.
    >> Share

  199. RAHMANIPOUR E, Sadeghi E, Arora S, Ghorbani M, et al
    Choroidal hypopigmented lesions: A review.
    Surv Ophthalmol. 2025 May 14:S0039-6257(25)00073.
    >> Share

  200. SINGH SR, Sadeghi E, Vupparaboina KK, Chhablani J, et al
    Recent updates in choroidal imaging biomarkers.
    Surv Ophthalmol. 2025 May 13:S0039-6257(25)00075.
    >> Share

  201. ERDAG M, Citirik M, Dal A
    Augmented and virtual reality in retinal care: A systematic review of their role in training, surgery, and treatment.
    Surv Ophthalmol. 2025 May 10:S0039-6257(25)00072.
    >> Share

  202. CHRONOPOULOS A, Schutz JS, Finger RP
    Prevention of rhegmatogenous retinal detachment.
    Surv Ophthalmol. 2025 May 6:S0039-6257(25)00071.
    >> Share

  203. CIFUENTES-GONZALEZ C, Le Tong Y, Rojas-Carabali W, Mejia-Salgado G, et al
    Systematic Review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3.
    Surv Ophthalmol. 2025 May 2:S0039-6257(25)00066.
    >> Share

  204. SADEGHI E, Colorado-Zavala MF, Almuhtaseb H, Venkatesh R, et al
    Anatomical and functional changes after internal limiting membrane peeling.
    Surv Ophthalmol. 2025;70:357-368.
    >> Share

  205. CHOPRA P, Fatima A, Mohapatra S, Murugaiyan K, et al
    Extracellular vesicles in dry eye disease and Sjogren's syndrome: A systematic review on their diagnostic and therapeutic role.
    Surv Ophthalmol. 2025;70:499-515.
    >> Share

    April 2025
  206. TAN JK, Steel DH, Ahmad S, Viswanathan A, et al
    Exploring the potential of Rho kinase inhibitors in ophthalmology: From mechanisms to clinical practice.
    Surv Ophthalmol. 2025 Apr 16:S0039-6257(25)00058.
    >> Share

  207. GRASSMEYER JJ, Pennesi ME, Yang P, Tschetter W, et al
    Effects of medications on the human electroretinogram: A comprehensive review.
    Surv Ophthalmol. 2025 Apr 12:S0039-6257(25)00067.
    >> Share

  208. UCAR F
    Comment on: "Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis".
    Surv Ophthalmol. 2025 Apr 3:S0039-6257(25)00065.
    >> Share

    March 2025
  209. MASTROGIUSEPPE E, Alisi L, Romaniello A, Caterino L, et al
    Managing Cutibacterium acnes endophthalmitis after cataract surgery: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Mar 29:S0039-6257(25)00061.
    >> Share

  210. AGARWAL A, Vempuluru VS, Kaliki S
    Primary Ocular, Adnexal, and Orbital Rhabdomyosarcoma: A Review.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00060.
    >> Share

  211. HUNG JH, Jain T, Khatri A, Nguyen TB, et al
    Inherited retinal diseases-associated uveitis.
    Surv Ophthalmol. 2025 Mar 27:S0039-6257(25)00057.
    >> Share

  212. SHAIKH N, Kumawat D, Chandra P, Senthil S, et al
    Glaucoma in retinopathy of prematurity - A review.
    Surv Ophthalmol. 2025 Mar 25:S0039-6257(25)00056.
    >> Share

  213. SIT AJ, Aihara M, Khawaja AP, Lin SC, et al
    Clinical implications of lowering episcleral venous pressure in the management of glaucoma and the use of Rho kinase inhibitors.
    Surv Ophthalmol. 2025 Mar 17:S0039-6257(25)00052.
    >> Share

  214. GHALEB R, Sallam AB, Grigorian F, Phillips PH, et al
    Oral fluorescein angiography in pediatric ophthalmology.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00051.
    >> Share

  215. CHEN Y, Jiang F, Zeng Y, Zhang M, et al
    The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00053.
    >> Share

  216. YAO A, Hussain A, Kannan R, Nduka C, et al
    Dynamic procedures for eyelid involvement in facial nerve palsy.
    Surv Ophthalmol. 2025 Mar 13:S0039-6257(25)00054.
    >> Share

  217. RODRIGUEZ-GARCIA A, Ruiz-Lozano RE, Barcelo-Canton RH, Marines-Sanchez HM, et al
    The Etiologic and Pathogenic Spectrum of Exposure Keratopathy: Diagnostic and Therapeutic Implications.
    Surv Ophthalmol. 2025 Mar 8:S0039-6257(25)00050.
    >> Share

  218. RICKELS KL, Ghaleb R, Elhusseiny AM, Chauhan MZ, et al
    Ocular manifestations secondary to cocaine abuse.
    Surv Ophthalmol. 2025 Mar 5:S0039-6257(25)00032.
    >> Share

  219. NEFFENDORF JE, Jackson TL
    Presumed phototoxicity from macular vital staining with Brilliant Blue G and Trypan Blue: A post-market surveillance study, systematic review, and synthesis of the literature.
    Surv Ophthalmol. 2025;70:339-351.
    >> Share

  220. LEI Y, Wang Y, Tang S, Yang J, et al
    The adaptive immune system in the retina of diabetics.
    Surv Ophthalmol. 2025;70:241-254.
    >> Share

  221. BHATTI MT, Fors DH, Muminovic I, Robbins SL, et al
    Heavy duty.
    Surv Ophthalmol. 2025;70:352-355.
    >> Share

  222. ZHANG Q, Wang S, Wang X, Xu C, et al
    Advancing Ophthalmology With Large Language Models: Applications, Challenges, and Future Directions.
    Surv Ophthalmol. 2025 Mar 1:S0039-6257(25)00037.
    >> Share

    February 2025
  223. DUNNIGAN JK, Wang CY, George L, Lee VA, et al
    Social Media in Ophthalmology: A Comprehensive Literature Review.
    Surv Ophthalmol. 2025 Feb 22:S0039-6257(25)00031.
    >> Share

  224. GHAFARIAN S, Samavat B, Lee K, Sheikhghomi S, et al
    Clinical strategies to prevent recurrence of Herpes simplex and Herpes zoster following ocular surgery: A comprehensive review with practical guidelines.
    Surv Ophthalmol. 2025 Feb 15:S0039-6257(25)00029.
    >> Share

  225. AL-DABET S, Turaev S, Zaki N
    Ocular-Induced Abnormal Head Postures: A Systematic Review and Analysis.
    Surv Ophthalmol. 2025 Feb 9:S0039-6257(25)00021.
    >> Share

  226. ZHANG C, Lai D, Zhu D, Palka C, et al
    Chlorhexidine for ocular antisepsis before intravitreal injection: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025 Feb 6:S0039-6257(25)00024.
    >> Share

  227. CIFUENTES-GONZALEZ C, Le Tong Y, Mejia-Salgado G, Chan R, et al
    Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1.
    Surv Ophthalmol. 2025 Feb 5:S0039-6257(25)00023.
    >> Share

    January 2025
  228. YANG Z, Tian D, Xie Z, Cheng T, et al
    Clinical features, diagnosis, management, and prognosis of circumscribed choroidal hemangioma.
    Surv Ophthalmol. 2025 Jan 23:S0039-6257(25)00011.
    >> Share

  229. SADEGHI E, Rahmanipour E, Valsecchi N, Kapoor S, et al
    An update on ocular effects of antidiabetic medications.
    Surv Ophthalmol. 2025 Jan 22:S0039-6257(25)00019.
    >> Share

  230. TURCAS C, Nicoara SD
    A comprehensive review of structure-function correlations in age-related macular degeneration: Contributions of microperimetry.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00017.
    >> Share

  231. ORTIZ-MORALES G, Ruiz-Lozano RE, Morales-Mancillas N, Homar Paez-Garza J, et al
    Pediatric blepharokeratoconjunctivitis: A challenging ocular surface disease.
    Surv Ophthalmol. 2025 Jan 17:S0039-6257(25)00009.
    >> Share

  232. BAYAT K, Pooyan P, Looha MA, Namakin K, et al
    Retinal structural alterations in patients with epilepsy taking antiepileptic drugs: A systematic review and meta-analysis of OCT findings.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00012.
    >> Share

  233. FORTE P, Paques M, Cattaneo J, Dupas B, et al
    Perifoveal vascular anomalous complex and telangiectatic capillaries: An overview of two entities potentially sharing a common pathophysiology.
    Surv Ophthalmol. 2025 Jan 15:S0039-6257(25)00014.
    >> Share

  234. FEO A, Stradiotto E, Govetto A, Forte P, et al
    Bacillary layer detachment: Updates on its clinical and prognostic significance in retinal disease.
    Surv Ophthalmol. 2025 Jan 14:S0039-6257(25)00013.
    >> Share

  235. DE LOTT LB, Kaplan C, Harte S, Clauw DJ, et al
    Nociplastic pain among individuals with chronic ocular surface pain: one cause for "pain without stain"?
    Surv Ophthalmol. 2025 Jan 13:S0039-6257(25)00015.
    >> Share

  236. LIU T, Elnahry AG, Tauqeer Z, Yu Y, et al
    Incidence and risk factors of perioperative suprachoroidal hemorrhage: A systematic review and meta-analysis.
    Surv Ophthalmol. 2025;70:54-62.
    >> Share

  237. YANG W, Ren R, Xie Y, Wang J, et al
    Diabetic uveopathy.
    Surv Ophthalmol. 2025;70:47-53.
    >> Share

  238. BHATTI MT, Long JR, Carey AR
    Denial.
    Surv Ophthalmol. 2025;70:162-166.
    >> Share

    December 2024
  239. LIN TH, Lin HY, Tseng PC
    Enhancing anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00157.
    >> Share

  240. NGOC VAN ANH L, Ngoc Cong N, Ngamjit K, Usanee R, et al
    Penetrating keratoplasty versus deep anteriror lamellar keratoplasty for macular corneal dystrophy: A meta-analysis.
    Surv Ophthalmol. 2024 Dec 19:S0039-6257(24)00156.
    >> Share

  241. SERVILLO A, Scandale P, Oldoni G, Begar PG, et al
    Inflammatory choroidal neovascularization: An evidence-based update.
    Surv Ophthalmol. 2024 Dec 18:S0039-6257(24)00155.
    >> Share

  242. JIRAVARNSIRIKUL A, Belghith A, Rezapour J, Bowd C, et al
    Evaluating glaucoma in myopic eyes: Challenges and opportunities.
    Surv Ophthalmol. 2024 Dec 17:S0039-6257(24)00154.
    >> Share

  243. SANTINA A, Feo A, Bousquet E, Velaga SB, et al
    Pentosan polysulfate sodium maculopathy: Final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease.
    Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00153.
    >> Share

  244. NAGINO K, Inomata T, Ohta T, Sung J, et al
    Postoperative complications of intrascleral intraocular lens fixation: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Dec 12:S0039-6257(24)00152.
    >> Share

    November 2024
  245. EIJGEN JV, Winckel LV, Hanssen H, Kotliar K, et al
    Retinal vessel analysis to assess microvascular function in the healthy eye: A systematic review on the response to acute physiological and pathological stressors.
    Surv Ophthalmol. 2024 Nov 24:S0039-6257(24)00140.
    >> Share

  246. RAI BB, Maddess T, Nolan CJ
    Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseases.
    Surv Ophthalmol. 2024 Nov 23:S0039-6257(24)00142.
    >> Share

  247. ISSA M, Sukkarieh G, Gallardo M, Sarbout I, et al
    Applications of artificial intelligence to inherited retinal diseases: A systematic review.
    Surv Ophthalmol. 2024 Nov 18:S0039-6257(24)00139.
    >> Share

  248. LEE SJV, FRCOphth, Goh YQ, Rojas-Carabali W, et al
    Association between retinal vessels caliber and systemic health: A comprehensive review.
    Surv Ophthalmol. 2024 Nov 16:S0039-6257(24)00138.
    >> Share

  249. VAHEB S, Panah MY, Shaygannejad V, Zabeti A, et al
    Uveitis among people with multiple sclerosis: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Nov 15:S0039-6257(24)00134.
    >> Share

  250. PUTERA I, Distia Nora R, Dewi AC, Suhada DS, et al
    Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Nov 14:S0039-6257(24)00141.
    >> Share

  251. RIZZO C, Savastano MC, Kilian R, Marchini G, et al
    Structural en face optical coherence tomography in neovascular and nonneovascularage-related macular degeneration: Use and utility in clinical practice.
    Surv Ophthalmol. 2024 Nov 8:S0039-6257(24)00135.
    >> Share

  252. LI L, Xiao K, Shang X, Hu W, et al
    Advances in artificial intelligence for meibomian gland evaluation: A comprehensive review.
    Surv Ophthalmol. 2024;69:945-956.
    >> Share

    October 2024
  253. ELSAYED MEA, Lander B, Senthil S, Edward DP, et al
    The Secondary Childhood Glaucomas.
    Surv Ophthalmol. 2024 Oct 30:S0039-6257(24)00132.
    >> Share

  254. SADEGHI E, Valsecchi N, Rahmanipour E, Ejlalidiz M, et al
    Choroidal biomarkers in age-related macular degeneration.
    Surv Ophthalmol. 2024 Oct 17:S0039-6257(24)00131.
    >> Share

  255. ALBRECHT M, Auffarth GU, Friedrich M, Kessler LJ, et al
    Vision degrading myodesopsia from vitreous floaters in the young: An important aspect of myopia.
    Surv Ophthalmol. 2024 Oct 16:S0039-6257(24)00128.
    >> Share

  256. NEWMAN NJ, Biousse V, Yu-Wai-Man P, Carelli V, et al
    Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber Hereditary Optic Neuropathy.
    Surv Ophthalmol. 2024 Oct 15:S0039-6257(24)00130.
    >> Share

  257. GUPTA Y, Devi C, Priyadarshini K, Mandal S, et al
    Pediatric Keratoconus.
    Surv Ophthalmol. 2024 Oct 11:S0039-6257(24)00129.
    >> Share

  258. HOVEN E, Michelet JT, Vettore MV, Lagali N, et al
    Choroidal thickness after anti-VEGF in typical neovascular age-related macular degeneration - A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Oct 5:S0039-6257(24)00124.
    >> Share

    September 2024
  259. MIKHAIL D, Milad D, Antaki F, Hammamji K, et al
    The role of artificial intelligence in macular hole management: A scoping review.
    Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00123.
    >> Share

  260. BERMAN G, Pendley AM, Wright DW, Silverman R, et al
    Breaking the barriers: Methodology of implementation of a non-mydriatic ocular fundus camera in an emergency department.
    Surv Ophthalmol. 2024 Sep 30:S0039-6257(24)00127.
    >> Share

  261. TAN JCK, Yohannan J, Ramulu PY, Kalloniatis M, et al
    Visual field testing in glaucoma using the Swedish Interactive Threshold Algorithm.
    Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00118.
    >> Share

  262. STALHAMMAR G, Hagstrom A, Ermedahl Conradi M, Williams PA, et al
    Choroidal nevi and melanoma doubling times and implications for delays in treatment: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Sep 28:S0039-6257(24)00117.
    >> Share

  263. ALISI L, Giovannetti F, Armentano M, Lucchino L, et al
    Challenging corneal diseases and miRNA expression: Focus on rare diseases and new therapeutic frontiers.
    Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00120.
    >> Share

  264. FERRO DESIDERI L, Sim PY, Bernardi E, Paschon K, et al
    Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage.
    Surv Ophthalmol. 2024 Sep 27:S0039-6257(24)00119.
    >> Share

  265. D'ALBENZIO A, Komici K, Affatato M, Castelluzzo AM, et al
    Vitreous Cortex Remnants in Patients With Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-analysis.
    Surv Ophthalmol. 2024 Sep 26:S0039-6257(24)00121.
    >> Share

  266. LEI C, Lv Z, Hua R, Duan J, et al
    Focal choroidal excavation: Review and updated pathogenesis.
    Surv Ophthalmol. 2024 Sep 25:S0039-6257(24)00126.
    >> Share

  267. YANG Q, Ju G, He Y
    Corneal densitometry: New evaluation indicator for corneal diseases.
    Surv Ophthalmol. 2024 Sep 24:S0039-6257(24)00122.
    >> Share

  268. WANG K, Liu Y, Li S, Zhao N, et al
    Unveiling the therapeutic potential and mechanisms of stanniocalcin-1 in retinal degeneration.
    Surv Ophthalmol. 2024 Sep 11:S0039-6257(24)00085.
    >> Share

  269. SUH A, Ditelberg S, Szeto JJ, Kumar D, et al
    Safety protocols, precautions, and countermeasures aboard the International Space Station (ISS) to prevent ocular injury.
    Surv Ophthalmol. 2024 Sep 3:S0039-6257(24)00097.
    >> Share

  270. L'ABBATE D, Prescott K, Geraghty B, Kearns VR, et al
    Biomechanical considerations for optimising subretinal injections.
    Surv Ophthalmol. 2024;69:722-732.
    >> Share

  271. TAWFIK HA, Ali MJ
    A major review on punctal stenosis: Part II: Updated therapeutic interventions, complications, and outcomes.
    Surv Ophthalmol. 2024;69:756-768.
    >> Share

  272. BIRCH EE, Duffy KR
    Leveraging neural plasticity for the treatment of amblyopia.
    Surv Ophthalmol. 2024;69:818-832.
    >> Share

  273. CHEN JS, Korn BS, Carey AR, Savino PJ, et al
    Looking beyond blurred margins.
    Surv Ophthalmol. 2024;69:842-846.
    >> Share

    August 2024
  274. CHAUHAN K, Dave VP, de Ribot FM, Agrawal R, et al
    Traumatic retinal detachment: A contemporary update.
    Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00101.
    >> Share

  275. MANO F, LoBue S, Tailor P, Olsen TW, et al
    Incisional choroidal surgery.
    Surv Ophthalmol. 2024 Aug 31:S0039-6257(24)00096.
    >> Share

  276. JESSUP AJC, Coroneo MT
    Examining the fabric of the eye: Antoni van Leeuwenhoek, the draper and ocular microscopist.
    Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00098.
    >> Share

  277. ZHAO Q, Wei L, Chen Y
    Detection of choroidal vascular features in diabetic patients without clinically visible diabetic retinopathy by optical coherence tomography angiography: A systemic review and meta-analysis.
    Surv Ophthalmol. 2024 Aug 28:S0039-6257(24)00100.
    >> Share

  278. SURICO PL, Barone V, Singh RB, Coassin M, et al
    Potential applications of mesenchymal stem cells in ocular surface immune-mediated disorders.
    Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00083.
    >> Share

  279. SCHLOESSER L, Klose SM, Mauschitz MM, Abdullah Z, et al
    The role of immune modulators in age-related macular degeneration.
    Surv Ophthalmol. 2024 Aug 1:S0039-6257(24)00084.
    >> Share

    July 2024
  280. MARMOR MF
    Lupus review is misleading about risk of hydroxychloroquine retinal toxicity.
    Surv Ophthalmol. 2024 Jul 24:S0039-6257(24)00082.
    >> Share

  281. ZHANG Z, Shan X, Li S, Chang J, et al
    Retinal light damage: From mechanisms to protective strategies.
    Surv Ophthalmol. 2024 Jul 23:S0039-6257(24)00079.
    >> Share

  282. VUJOSEVIC S, Lupidi M, Donati S, Astarita C, et al
    Role of inflammation in diabetic macular edema and neovascular age-related macular degeneration.
    Surv Ophthalmol. 2024 Jul 17:S0039-6257(24)00080.
    >> Share

  283. FOUAD YA, Cicinelli MV, Marchese A, Casalino G, et al
    Revisiting acute retinal pigment epitheliitis (Krill disease).
    Surv Ophthalmol. 2024 Jul 16:S0039-6257(24)00078.
    >> Share

  284. TORKASHVAND A, Izadian A, Hajrasouliha A
    Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions.
    Surv Ophthalmol. 2024 Jul 8:S0039-6257(24)00076.
    >> Share

  285. HASHEMI E, Looha MA, Mazaherinia H, Samadaeian N, et al
    Risk of stroke development following retinal vein occlusion: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 Jul 3:S0039-6257(24)00074.
    >> Share

  286. SINCLAIR SH, Schwartz S
    Diabetic retinopathy: New concepts of screening, monitoring, and interventions.
    Surv Ophthalmol. 2024 Jul 2:S0039-6257(24)00077.
    >> Share

  287. WU H, Jin K, Yip CC, Koh V, et al
    A systematic review of economic evaluation of artificial intelligence-based screening for eye diseases: From possibility to reality.
    Surv Ophthalmol. 2024;69:499-507.
    >> Share

  288. BUNJO LJ, Bacchi S, Pietris J, Chan WO, et al
    Current management options for the treatment of refractory postoperative cystoid macular edema: A systematic review.
    Surv Ophthalmol. 2024;69:606-621.
    >> Share

  289. LEIDY L, Dickinson A, Ramulu P, Ehrlich J, et al
    Clinical outcome measures in vision and eye care.
    Surv Ophthalmol. 2024;69:632-637.
    >> Share

    June 2024
  290. HOSSEINI F, Asadi F, Rabiei R, Kiani F, et al
    Applications of artificial intelligence in diagnosis of uncommon cystoid macular edema using optical coherence tomography imaging: A systematic review.
    Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00073.
    >> Share

  291. PARRAVANO M, Cennamo G, Di Antonio L, Grassi MO, et al
    Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers.
    Surv Ophthalmol. 2024 Jun 26:S0039-6257(24)00075.
    >> Share

  292. DAUNGSUPAWONG H, Wiwanitkit V
    Generative artificial intelligence in ophthalmology: Correspondence.
    Surv Ophthalmol. 2024 Jun 17:S0039-6257(24)00071.
    >> Share

  293. FARAHAT Z, Zrira N, Souissi N, Bennani Y, et al
    Diabetic retinopathy screening through artificial intelligence algorithms: A systematic review.
    Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00051.
    >> Share

  294. POSARELLI M, Passaro ML, Avolio FC, Costagliola C, et al
    The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment.
    Surv Ophthalmol. 2024 Jun 15:S0039-6257(24)00069.
    >> Share

  295. WAISBERG E, Ong J, Masalkhi M, Lee AG, et al
    Future directions of generative artificial intelligence in ophthalmology and vision science.
    Surv Ophthalmol. 2024 Jun 14:S0039-6257(24)00072.
    >> Share

    May 2024
  296. BACHMEIER I, Armendariz BG, Yu S, Jager RJ, et al
    Corrigendum to "Fibrosis in neovascular age-related macular degeneration: a review of definitions based on clinical imaging" [Surv Ophthalmol 68 (2023) 835-848/5].
    Surv Ophthalmol. 2024 May 28:S0039-6257(23)00137.
    >> Share

  297. HERNANDEZ RF, Rodriguez JEM, Trecu MS, Tariq Bhatti M, et al
    Not everything is ischemic optic neuropathy.
    Surv Ophthalmol. 2024 May 23:S0039-6257(24)00054.
    >> Share

  298. VEMPULURU VS, Maniar A, Bakal K, Kaliki S, et al
    Role of MYCN in Retinoblastoma: A Review of Current Literature.
    Surv Ophthalmol. 2024 May 23:S0039-6257(24)00055.
    >> Share

  299. CHENG T, Gu X, Yang Z, Wang C, et al
    Clinical features of ocular damage in systemic lupus erythematosus and risk factors of hydroxychloroquine related complications.
    Surv Ophthalmol. 2024 May 21:S0039-6257(24)00052.
    >> Share

  300. KNECHT KT, Chiriac G, Guan HD
    The potential impact of a vegetarian diet on glaucoma.
    Surv Ophthalmol. 2024 May 18:S0039-6257(24)00048.
    >> Share

  301. WAISBERG E, Ong J, Kamran SA, Masalkhi M, et al
    Generative artificial intelligence in ophthalmology.
    Surv Ophthalmol. 2024 May 16:S0039-6257(24)00044.
    >> Share

  302. FEKRAZAD S, Hassanzadeh G, Salehi MA, Mozafar M, et al
    Optical coherence tomography angiography measurements in systemic lupus erythematosus: A systematic review and meta-analysis.
    Surv Ophthalmol. 2024 May 12:S0039-6257(24)00047.
    >> Share

  303. TRINCAO-MARQUES TM, Ayton LN, Hickey DG, Marques-Neves C, et al
    Gene and cell therapy for age-related macular degeneration: A review.
    Surv Ophthalmol. 2024 May 10:S0039-6257(24)00049.
    >> Share

  304. NIAZI S, Doroodgar F, Nazari SH, Rahimi Y, et al
    Refractive surgical approaches to keratoconus: A systematic review and network meta-analysis.
    Surv Ophthalmol. 2024 May 4:S0039-6257(24)00045.
    >> Share

  305. TAWFIK HA, Ali MJ
    A major review of punctal stenosis: Updated anatomy, epidemiology, etiology, and clinical presentation.
    Surv Ophthalmol. 2024;69:441-455.
    >> Share

  306. HUANG RS, Mihalache A, Popovic MM, Cruz-Pimentel M, et al
    Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Surv Ophthalmol. 2024;69:456-464.
    >> Share

  307. ROY R, Chattree S, Kala U, Majumdar B, et al
    Multicolor imaging: Current clinical applications.
    Surv Ophthalmol. 2024;69:378-402.
    >> Share

  308. ARORA S, Zur D, Iovino C, Chhablani J, et al
    Peripapillary fluid: Obvious and not so obvious!
    Surv Ophthalmol. 2024;69:311-329.
    >> Share

  309. PELLEGRINI F, Basciu M, Foroozan R
    Planet of the apex.
    Surv Ophthalmol. 2024;69:495-498.
    >> Share

    April 2024
  310. VERA-DUARTE GR, Jimenez-Collado D, Kahuam-Lopez N, Ramirez-Miranda A, et al
    Neurotrophic keratopathy: General features and new therapies.
    Surv Ophthalmol. 2024 Apr 26:S0039-6257(24)00042.
    >> Share

  311. LEE YM, Bahrami B, Selva D, Casson RJ, et al
    Scoping review of non-surgical treatment options for macular holes.
    Surv Ophthalmol. 2024 Apr 25:S0039-6257(24)00043.
    >> Share

  312. KANG C, Lee MJ, Chomsky A, Oetting TA, et al
    Risk factors for complications in resident-performed cataract surgery: A systematic review.
    Surv Ophthalmol. 2024 Apr 20:S0039-6257(24)00032.
    >> Share

  313. SALEHI MA, Frounchi N, Zakavi SS, Mohammadi S, et al
    Retinal and choroidal changes after anti-VEGF therapy in Neovascular-AMD Patients: A Systematic Review and Meta-Analysis of SD-OCT studies.
    Surv Ophthalmol. 2024 Apr 17:S0039-6257(24)00033.
    >> Share

  314. KROLO I, Behaegel J, Termote K, de Bruyn B, et al
    The role of topical insulin on ocular surface restoration: A review.
    Surv Ophthalmol. 2024 Apr 10:S0039-6257(24)00031.
    >> Share

    March 2024
  315. ARDA H, Maier M, Schultheiss M, Haritoglou C, et al
    Advances in management strategies for large and persistent macular hole: an update.
    Surv Ophthalmol. 2024 Mar 27:S0039-6257(24)00030.
    >> Share

  316. NOURI H, Abtahi SH, Mazloumi M, Samadikhadem S, et al
    Optical coherence tomography angiography in diabetic retinopathy: A major review.
    Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00021.
    >> Share

  317. BRESSLER NM, Kaiser PK, Do DV, Nguyen QD, et al
    Biosimilars of anti-vascular endothelial growth factor for ophthalmic diseases: A review.
    Surv Ophthalmol. 2024 Mar 21:S0039-6257(24)00029.
    >> Share

  318. SCHEFFER M, Menting J, Boeije H, van Nispen R, et al
    Understanding healthcare communication in age-related macular degeneration care: A mixed-methods review of patients' perspectives.
    Surv Ophthalmol. 2024 Mar 16:S0039-6257(24)00018.
    >> Share

  319. SABATINO F, Banerjee P, K Muqit MM
    Clinical therapeutics for proliferative vitreoretinopathy in retinal detachment.
    Surv Ophthalmol. 2024 Mar 15:S0039-6257(24)00024.
    >> Share

  320. ANG T, Chaggar V, Tong JY, Selva D, et al
    Medication-associated orbital inflammation: A systematic review.
    Surv Ophthalmol. 2024 Mar 13:S0039-6257(24)00020.
    >> Share

  321. ORTIZ-SELLER A, Martorell P, Barranco H, Pascual-Camps I, et al
    Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis.
    Surv Ophthalmol. 2024 Mar 1:S0039-6257(24)00008.
    >> Share

  322. OO HH, Mohan M, Song W, Rojas-Carabali W, et al
    Anterior chamber inflammation grading methods: A critical review.
    Surv Ophthalmol. 2024;69:253-264.
    >> Share

  323. YESILTAS YS, Oakey Z, Wrenn J, Yeaney G, et al
    Uveal melanoma in African Americans: Diagnostic challenges.
    Surv Ophthalmol. 2024;69:190-197.
    >> Share

  324. ARNOLD RW
    Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
    Surv Ophthalmol. 2024;69:295.
    >> Share

  325. ROBBINS SL, Greenberg M, Juan I
    Surgical and anesthetic influences of the oculocardiac reflex in adults and children during strabismus surgery.
    Surv Ophthalmol. 2024;69:S0039-625700087-5.
    >> Share

    February 2024
  326. JIANG F, Lei C, Chen Y, Zhou N, et al
    The complement system and diabetic retinopathy.
    Surv Ophthalmol. 2024 Feb 23:S0039-6257(24)00007.
    >> Share

    September 2023
  327. PELLEGRINI F, Basciu M, Falardeau J
    Pole to pole.
    Surv Ophthalmol. 2023;68:1002-1005.
    >> Share

  328. MA F, Yuan M, Kozak I
    Multispectral imaging: Review of current applications.
    Surv Ophthalmol. 2023;68:889-904.
    >> Share

  329. WOUDSTRA-DE JONG JE, Manning-Charalampidou SS, Vingerling H, Busschbach JJ, et al
    Patient-reported outcomes in patients with vitreous floaters: A systematic literature review.
    Surv Ophthalmol. 2023;68:875-888.
    >> Share

  330. TONG JY, Huilgol SC, James C, Selva D, et al
    Recommendations for risk stratification of periocular squamous cell carcinoma.
    Surv Ophthalmol. 2023;68:964-976.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016